Purolite Grows Bioprocessing Production Capacity with New U.S. Manufacturing Facility
06 Junho 2023 - 9:30AM
Business Wire
Landenberg site strengthens supply to support
lifesaving therapeutics for global customers
Ecolab Inc., the world’s water, hygiene and infection prevention
company, today announced a further expansion of its Purolite
business with the addition of a new biologics resin manufacturing
facility in Landenberg, Pennsylvania. Construction plans for the
new facility are underway and will strengthen the security of
supply for global pharmaceutical and biotech customers and will
support the continued development and production of lifesaving
clinical and commercial-scale therapeutics for patients
worldwide.
“We are excited to announce this new facility, because of what
it will mean for our customers and the many healthcare patients
around the world who benefit from their innovation. As Purolite
continues to grow, we are committed to continued chromatography
innovation and dedicated applications support, thus improving the
global supply of the high-quality products to produce lifesaving
and life-enhancing therapeutics,” said Hayley Crowe, Senior Vice
President and General Manager, Purolite.
The expansion plans for the new U.S. location include the
construction of resin production facilities, cleanrooms,
laboratories and new office space. Additional land is available at
the site for future expansion to meet potential growth needs of the
Purolite business. The Landenberg facility will be Purolite’s
fourth location in Pennsylvania, further solidifying their
commitment to the creation of new skilled jobs and the growth of
the state’s economy. Once completed, the new facility is expected
to significantly expand production capacity and add more than 150
skilled jobs in the next five years.
“The Commonwealth of Pennsylvania is home to a growing biotech
industry, and with Purolite’s expansion in Chester County, we are
cementing ourselves as one of the leaders in this rapidly expanding
field,” said Governor Josh Shapiro. “I’m proud that Pennsylvania
won this expansion project against other states, and I’m pleased
that we will be the home of Purolite’s first U.S. Biologics
Division. These types of strategic investments in growing
businesses are positioning the Commonwealth as an economic
powerhouse, and we will continue to make investments that bring
more expansions and good-paying jobs to the Commonwealth.”
The Landenberg location will be Purolite’s sixth manufacturing
facility globally. It will produce high-quality agarose
chromatography resin for downstream monoclonal antibody and
recombinant protein purification, and it will support new modality
purification across cell therapy, gene therapy and mRNA. The
expanded production capacity will allow Purolite to better support
innovators worldwide with premier purification resin that will
increase yield, optimize productivity and reduce the time needed to
bring lifesaving therapeutics to market.
About Ecolab
A trusted partner for millions of customers, Ecolab (NYSE:ECL)
is a global sustainability leader offering water, hygiene and
infection prevention solutions and services that protect people and
the resources vital to life. Building on a century of innovation,
Ecolab has annual sales of $14 billion, employs more than 47,000
associates and operates in more than 170 countries around the
world. The company delivers comprehensive science-based solutions,
data-driven insights and world-class service to advance food
safety, maintain clean and safe environments, and optimize water
and energy use. Ecolab’s innovative solutions improve operational
efficiencies and sustainability for customers in the food,
healthcare, life sciences, hospitality and industrial markets.
www.ecolab.com
Follow us on LinkedIn @Ecolab, Twitter @Ecolab, Instagram
@Ecolab_Inc and Facebook @Ecolab.
About Purolite
Purolite, an Ecolab company, is a global leader in resin
technology and services. They develop and manufacture very small
beads that purify substances in the most regulated industries in
the world. Industries like biopharma, pharma, microelectronics, and
nuclear power depend on their solutions to separate, remove, or
recover very specific elements and compounds. In the fast growing
$3 billion life sciences market, Purolite provides critical
solutions to help its customers produce high quality biologics for
chronic illnesses and disease. With a large technical sales team,
five R&D centers and six manufacturing facilities, they are
built to provide high-end, customized solutions to address some of
the most complex challenges. www.purolite.com
(ECL-C)
View source
version on businesswire.com: https://www.businesswire.com/news/home/20230606005334/en/
Victoria Whitney 651-250-4724 MediaRelations@Ecolab.com
Ecolab (NYSE:ECL)
Gráfico Histórico do Ativo
De Abr 2024 até Mai 2024
Ecolab (NYSE:ECL)
Gráfico Histórico do Ativo
De Mai 2023 até Mai 2024